A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study ...

Two clinical trials of dementia care programs report negative results in terms of patient neuropsychiatric symptoms and ...

Guillain-Barré Syndrome (GBS) is a rare neurological condition that causes muscle weakness and can lead to paralysis. Linked ...

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

A $10.3 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, will fund ...

Their apathy levels were measured by the Neuropsychiatric Inventory (NPI)—a questionnaire that assesses 12 neuropsychiatric ...

Use of montelukast not associated with risk of neuropsychiatric adverse events among children suggests a new study published in the JAMA.Spontaneous reports have indicated that ...

IN-PEACE, which provides palliative care integrated with state-of-the-art dementia care to patients with dementia and their ...

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...